Nobuo Aoki
#154,574
Most Influential Person Now
Nobuo Aoki's AcademicInfluence.com Rankings
Nobuo Aokiphilosophy Degrees
Philosophy
#8691
World Rank
#12116
Historical Rank
Logic
#5721
World Rank
#7143
Historical Rank

Download Badge
Philosophy
Nobuo Aoki's Degrees
- PhD Medicine University of Tokyo
- Doctorate Medicine University of Tokyo
Why Is Nobuo Aoki Influential?
(Suggest an Edit or Addition)Nobuo Aoki's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Efficacy and safety of recombinant human soluble thrombomodulin (ART‐123) in disseminated intravascular coagulation: results of a phase III, randomized, double‐blind clinical trial (2007) (532)
- Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. (1990) (516)
- Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. (1976) (408)
- Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. (1980) (361)
- Mediation of cardioprotection by transforming growth factor-beta. (1990) (307)
- Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. (1982) (284)
- Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis. (1978) (241)
- A novel vascular relaxing agent, N-(6--aminohexyl)-5-chloro-1-naphthalensulfonamide which affects vascular smooth muscle actomyosin. (1978) (172)
- Congenital Deficiency of α2-Plasmin Inhibitor Associated with Severe Hemorrhagic Tendency (1979) (170)
- Monoclonal antibodies to discrete regions in alpha 2-plasmin inhibitor. (1987) (147)
- A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese. (1997) (139)
- The behavior of alpha2-plasmin inhibitor in fibrinolytic states. (1977) (131)
- Anti-EDRF effect of tumor necrosis factor in isolated, perfused cat carotid arteries. (1989) (129)
- Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor. (1986) (124)
- Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor. (1982) (123)
- Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation. (1997) (118)
- Acute effects of cigarette smoking on platelet-dependent thrombin generation. (2001) (117)
- THROMBOMODULIN ALFA IN THE TREATMENT OF INFECTIOUS PATIENTS COMPLICATED BY DISSEMINATED INTRAVASCULAR COAGULATION: SUBANALYSIS FROM THE PHASE 3 TRIAL (2011) (109)
- Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. (1997) (104)
- Platelet-dependent thrombin generation in patients with diabetes mellitus: effects of glycemic control on coagulability in diabetes. (1996) (98)
- Factor XIII‐mediated cross‐linking of NH2‐terminal peptide of α2‐plasmin inhibitor to fibrin (1983) (98)
- Plasminogen Tochigi: inactive plasmin resulting from replacement of alanine-600 by threonine in the active site. (1982) (93)
- Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock. (1990) (93)
- Natural inhibitors of fibrinolysis. (1979) (91)
- Conformation-specific monoclonal antibodies to the calcium-induced structure of protein C. (1986) (89)
- Effect of Protein C and Activated Protein C on Coagulation and Fibrinolysis in Normal Human Subjects (1990) (89)
- Platelet-dependent thrombin generation in patients with hyperlipidemia. (1997) (86)
- Cross-linking of α2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor (1981) (84)
- A Comparative Double-Blind Randomized Trial of Activated Protein C and Unfractionated Heparin in the Treatment of Disseminated Intravascular Coagulation (2002) (84)
- Release of arachidonic acid from human platelets. A key role for the potentiation of platelet aggregability in normal subjects as well as in those with nephrotic syndrome. (1978) (74)
- DISTRIBUTION OF COLD‐INSOLUBLE GLOBULIN IN PLASMA AND TISSUES * (1978) (73)
- Expression and characterization of pro alpha 2-plasmin inhibitor. (1989) (63)
- Congenital α2‐plasmin inhibitor deficiencies: a review (2001) (62)
- Regulatory mechanisms for thrombomodulin expression in human umbilical vein endothelial cells in vitro (1991) (61)
- Inhibition of plasminogen binding to fibrin by α2-plasmin inhibitor☆ (1977) (61)
- Assay of alpha2-plasmin inhibitor activity by means of a plasmin specific tripeptide substrate. (1978) (59)
- Purpura fulminans in a Chinese boy with congenital protein C deficiency. (1986) (59)
- Fibrinolytic States in a Patient with Congenital Deficiency of Alpha 2-Plasmin Inhibitor (1980) (55)
- Molecular basis for Glanzmann's thrombasthenia (GT) in a compound heterozygote with glycoprotein IIb gene: a proposal for the classification of GT based on the biosynthetic pathway of glycoprotein IIb-IIIa complex. (1992) (54)
- Treatment of patients with disseminated intravascular coagulation by protein C (1990) (52)
- Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin. (1978) (52)
- Acceleration of fibrinolysis by the N-terminal peptide of alpha 2-plasmin inhibitor. (1985) (51)
- Endothelium and myocardial protecting actions of taprostene, a stable prostacyclin analogue, after acute myocardial ischemia and reperfusion in cats. (1990) (49)
- Hemostasis associated with abnormalities of fibrinolysis. (1989) (49)
- Different NH2-terminal form with 12 additional residues of alpha 2-plasmin inhibitor from human plasma and culture media of Hep G2 cells. (1994) (48)
- Excessive fibrinolysis in suspected amyloidosis: Demonstration of plasmin‐α2‐plasmin inhibitor complex and von Willebrand factor fragment in plasma (1986) (46)
- Organization of the human alpha 2-plasmin inhibitor gene. (1988) (45)
- Molecular abnormality of plasminogen. (1980) (45)
- Congenital alpha(2)-plasmin inhibitor deficiencies: a review. (2001) (45)
- Effects of α2-Plasmin Inhibitor on Fibrin Clot Lysis. Its Comparison with α2-Macroglobulin (1978) (44)
- Inhibitory spectrum of alpha 2-plasmin inhibitor. (1979) (44)
- Molecular basis for Glanzmann's thrombasthenia (GT) in a compound heterozygote with glycoprotein IIb gene: a proposal for the classification of GT based on the biosynthetic pathway of glycoprotein IIb-IIIa complex (1992) (42)
- Review of a case of tsutsugamushi disease showing myocarditis and confirmation of Rickettsia by endomyocardial biopsy. (1991) (41)
- Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site. (1988) (41)
- Inhibition of platelet aggregation by protease inhibitors. Possible involvement of proteases in platelet aggregation (1978) (41)
- Differential binding of plasminogen to crosslinked and noncrosslinked fibrins: its significance in hemostatic defect in factor XIII deficiency. (1984) (40)
- Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency. (1979) (39)
- Autoantibody against platelet glycoprotein IIb/IIIa in a patient with non-Hodgkin's lymphoma. (1989) (38)
- Reversible cross-linking of α2-plasmin inhibitor to fibrinogen by fibrin-stabilizing factor (1982) (36)
- Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis. (1986) (34)
- Histidine-rich glycoprotein and alpha 2-plasmin inhibitor in inhibition of plasminogen binding to fibrin. (1984) (30)
- Factor XIII-mediated cross-linking of NH2-terminal peptide of alpha 2-plasmin inhibitor to fibrin. (1983) (30)
- Mental stress and physical exercise increase platelet-dependent thrombin generation (2000) (29)
- Anti-Shock Effects of Human Superoxide Dismutase in Splanchnic Artery Occlusion (SAO) Shock (1988) (29)
- Influence of α2-plasmin inhibitor on adsorption of plasminogen to fibrin (1980) (29)
- Alpha 2-Plasmin inhibitor is among acute phase reactants. (1980) (29)
- Preparation of thrombomodulin from human placenta. (1985) (29)
- Direct cardiovascular actions of two metabolites of linoleic acid. (1990) (28)
- Preparation of plasminogen activator from vascular trees of human cadavers. Its comparison with urokinase. (1974) (27)
- Thrombasthenia with an abnormal platelet membrane glycoprotein IIb of different molecular weight. (1988) (26)
- Frequencies of prothrombin 20210 G-->A mutation may be different among races--studies on Japanese populations with various forms of thrombotic disorders and healthy subjects. (1998) (26)
- Human platelet activation by thrombolytic agents: effects of tissue-type plasminogen activator and urokinase on platelet surface P-selectin expression. (1998) (24)
- Monoclonal antibodies to human thrombomodulin whose binding is calcium dependent. (1989) (24)
- Cross-linking of alpha 2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor. (1981) (24)
- Plasminogens Tochigi II and Nagoya: two additional molecular defects with Ala-600----Thr replacement found in plasmin light chain variants. (1984) (24)
- Restriction fragment length polymorphism caused by a deletion involving Alu sequences within the human alpha 2-plasmin inhibitor gene. (1989) (24)
- On the interaction of alpha2-plasmin inhibitor and proteases. Evidence for the formation of a covalent crosslinkage and non-covalent weak bondings between the inhibitor and proteases. (1977) (23)
- Relationship between post‐translational glycosylation and anticoagulant function of secretable recombinant mutants of human thrombomodulin (1991) (23)
- Recombinant human soluble thrombomodulin (thrombomodulin alfa) to treat disseminated intravascular coagulation in solid tumors: results of a one-arm prospective trial (2015) (23)
- Discovery of α2‐plasmin inhibitor and its congenital deficiency (2004) (23)
- Urinary thrombomodulin, its isolation and characterization. (1993) (22)
- Leukocyte-dependent and leukocyte-independent mechanisms of impairment of endothelium-mediated vasodilation. (1990) (21)
- Treatment of DIC with antithrombin III concentrates. (1983) (21)
- Shear‐induced platelet aggregation increases in patients with proximal and severe coronary artery stenosis (2002) (20)
- The alpha2-plasmin inhibitor levels in liver diseases. (1978) (20)
- Fibrinolysis: Its initiation and regulation (1986) (19)
- Potentiation by collagen or epinephrine of platelet responsiveness to aggregation. The possible role of substance(s) released from platelet membranes. (1977) (19)
- Fibrin-associated plasminogen activation in alpha 2-plasmin inhibitor deficiency (1983) (19)
- Structure of the Carboxyl-Terminal Half of Human α2-Plasmin Inhibitor Deduced from That of cDNA (1986) (18)
- Inhibition of proteases in coagulation, kinin-forming and complement systems by alpha2-plasmin inhibitor. (1977) (18)
- Differences of frequency distributions of plasminogen phenotypes between Japanese and American populations: New methods for the detection of plasminogen variants (1984) (17)
- The past, present and future of plasmin inhibitor. (2005) (17)
- Anti-shock effects of human superoxide dismutase in splanchnic artery occlusion (SAO) shock. (1988) (16)
- Localization of urinary procoagulant in the human kidney. (1979) (16)
- Reversible cross-linking of alpha 2-plasmin inhibitor to fibrinogen by fibrin-stabilizing factor. (1982) (15)
- The link between free radicals and myocardial injury. (1988) (15)
- Inhibition of platelet function by a calmodulin interacting agent, W-7. (1981) (15)
- Genetic polymorphism of human plasminogen in a Japanese population. (1982) (15)
- Protection of the rat myocardium from ischemic injury by dietary lamprey oil. (1988) (14)
- Urinary procoagulant behaves as tissue factor by promoting factor VIIa-catalyzed activation of factor X. (1984) (14)
- Cross-linking of cxz-Plasmin Inhibitor to Fibrin Catalyzed by Activated Fibrin-stabilizing Factor * (2001) (13)
- Clot Retraction Increases Clot Resistance to Fibrinolysis by Condensing α2-Plasmin Inhibitor Crosslinked to Fibrin (1993) (13)
- Heterozygote for plasmin inhibitor deficiency developing hemorrhagic tendency with advancing age. (1996) (12)
- FUNCTION OF AC-GLOBULIN AND LIPID IN BLOOD CLOTTING. (1963) (12)
- Purification and characterization of procoagulant in human urine. (1978) (11)
- Clinical Pharmacology of a New Antithrombotic Agent, Ticlo (1978) (11)
- Influence of alpha 2-plasmin inhibitor on adsorption of plasminogen to fibrin. (1980) (10)
- Calcium-dependent binding of α2-plasmin inhibitor to fibrin (1979) (10)
- Isolation and Characterization of a 2-Plasmin Inhibitor from Human Plasma (2002) (10)
- Inhibition of platelet aggregation by protease inhibitors. Possible involvement of proteases in platelet aggregation. (1978) (10)
- Association of human alpha1-antitrypsin with anhydrotrypsin. (1975) (10)
- Human alpha 2-plasmin inhibitor. (1993) (9)
- Mechanism of Rethrombosis After Thrombolytic Therapy: Angioscopic Findings and Investigation of the Coagulation System in Dogs (1998) (9)
- Distinction of Serum Inhibitor of Activator-Induced Clot Lysis from α1-Antitrypsin (1974) (9)
- Molecular genetics of alpha 2 plasmin inhibitor. (1990) (8)
- [A case of acute promyelocytic leukemia with skin nodules and mammary tumors during hematologic remission (author's transl)]. (1978) (8)
- Coronary endothelium-protective effects of defibrotide in ischaemia and reperfusion (1990) (8)
- Effects of medroxyprogesterone acetate therapy on advanced or recurrent breast cancer and its influences on blood coagulation and the fibrinolytic system (1995) (8)
- Chronic lymphocytic leukemia of T-cell origin: demonstration in two cases by the use of anti-thymocyte membrane antiserum. (1974) (8)
- Beneficial mechanisms of action of a prostacyclin enhancing agent in splanchnic artery occlusion shock. (1988) (8)
- A Single Thymine Nucleotide Deletion Responsible for Congenital Deficiency of Plasmin Inhibitor (2002) (8)
- Fibrin-associated plasminogen activation in alpha 2-plasmin inhibitor deficiency. (1983) (7)
- Assignment of the human alpha 2-plasmin inhibitor gene (PLI) to chromosome region 18p11.1----q11.2 by in situ hybridization. (1988) (7)
- A Novel Polymorphism, 70Leu/Phe, Disrupts a Consensus Leu Residue within the Leucine-rich Repeat Sequence of Platelet Glycoprotein Ibα (2002) (7)
- Discovery of alpha2-plasmin inhibitor and its congenital deficiency. (2005) (6)
- Survival of transfused α2-plasmin inhibitor in a patient with its congenital deficiency (1981) (6)
- PROVEST AND BLOOD COAGULATION TESTS. (1963) (6)
- Statistics on underlying and causative diseases of DIC in Japan: a cooperative study. (1983) (5)
- Antithrombin III concentrate in the treatment of fulminant hepatic failure (1988) (5)
- The initiation of fibrinolysis in α2-plasmin inhibitor deficient plasma. Role of fibrin (1986) (5)
- Purification of Human α2 -Plasmin Inhibitor Using Monoclonal Antibody Column Chromatography (1989) (5)
- Fundamental Function of Ac-globulin and Lipid in Blood Clotting (1963) (4)
- Calcium-dependent binding of alpha 2-plasmin inhibitor to fibrin. (1979) (4)
- Structure of the carboxyl-terminal half of human alpha 2-plasmin inhibitor deduced from that of cDNA. (1986) (4)
- [Assessment of global and regional LV function obtained by quantitative gated SPECT using 99mTc-tetrofosmin: comparison with left ventricular cineangiography and echocardiography]. (1998) (4)
- Clinical Significance of Hypoxemia without Congestive Heart Failure in Patients Presenting with Acute Myocardial Infarction (1997) (4)
- Protective effects of thromboxane receptor blockade in splanchnic artery occlusion shock. (1988) (3)
- Inhibition of plasminogen binding to fibrin by alpha2-plasmin inhibitor. (1977) (3)
- [Evaluation of the assay for alpha 2PI and alpha 2PI-plasmin complex using the one-step sandwich method (EIA)]. (1987) (3)
- Effects of repeated brief episodes of ischemia and reperfusion in isolated perfused rat hearts (2006) (3)
- Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock. (1989) (3)
- Fibrin-Associated Plasminogen Activation in a 2 Pli min Inhibitor Deficiency (2005) (3)
- Platelet-Dependent Thrombin Generation in Patients with Unstable Angina Pectoris (2001) (2)
- FIBRINOGENS KYOTO AND TOCHIGI, EACH WITH AN APPARENT ABNORMAL MOL. WT. γ CHAIN, ARE CHARACTERIZED BY REPLACEMENT OF γ ASN-308 BY LYS AND γ ARG-275 BY CYS, RESPECTIVELY (1987) (2)
- Purification of human alpha 2-plasmin inhibitor by a one-step immunoaffinity chromatography procedure. (1992) (2)
- Release of Arachidonic Acid From Human Platelets (2005) (2)
- Identification of free radical species in the myocardium. (1988) (2)
- [Pathogenesis of von Willebrand's disease]. (1978) (1)
- STRUCTURE OF HUMAN α2-PLASMIN INHIBITOR DEDUCED FROM THAT OF cDNA (1987) (1)
- α2-Plasmin Inhibitor: A Novel Inhibitor of Blood Coagulation and Kinin Generation (1977) (1)
- A case of dermatomyositis associated with recurrent mediastinal emphysema (1986) (1)
- Plasma level of cold-insoluble globulin in liver diseases, especially in liver cirrhosis and its clinical implications (1981) (1)
- Japanese not hypersensitive to warfarin. (1971) (1)
- The initiation of fibrinolysis in alpha 2-plasmin inhibitor deficient plasma. Role of fibrin. (1986) (1)
- [Molecular abnormalities of coagulation-fibrinolysis factors]. (1980) (1)
- Hypertension and dietary habit (1988) (1)
- Direct positive inotropic and vasoconstrictor effects of endothelin (2005) (1)
- α2-Plasmin inhibitor: Inhibitory regulator of fibrinolytic system (1986) (1)
- The Behavior of a2-Plasmin Inhibitor in Fibrinolytic States (2013) (1)
- [The determination of antiactivator; especially inhibitors against the activator-induced fibrin clot lysis (author's transl)]. (1976) (0)
- [An autopsy case of adult T-cell leukemia with extensive involvement of the lung (author's transl)]. (1980) (0)
- [Effects of alpha2-macroglobulin and FDP on the antithrombin III assay system (author's transl)]. (1977) (0)
- Klippel-Trénaunay-Weber Syndrome Complicated by DIC Associated with Bone Fracture (1991) (0)
- Purification of human alpha 2-plasmin inhibitor using monoclonal antibody column chromatography. (1989) (0)
- -255-A RAPID AND SINPLE TECHNIQUE FOR THE IDENTIFICATION OF NECROTIC AREA WITH NADH FLUOROPHOTOGRAPHY AND NAD^+ & NADH VALUES IN THE MYOCARDIUM (1986) (0)
- [The use of antithrombin III concentrates in disseminated intravascular coagulation]. (1982) (0)
- [alpha2-plasmin inhibitor (author's transl)]. (1978) (0)
- Distribution And Localization Of Urinary Procoagulant In The Human Kidney And Its Immunologically Cross-Reactive Substances In Various Exocrine Glands (1981) (0)
- [Evaluation of quantitative analysis of serum protein by immunological methods]. (1971) (0)
- BRIEF COMMUNICATION PURIFICATION OF HUMAN an-PLASMIN INHIBITOR BY A ONE-STEP IMMUNOAFFINITY CHROMATOGRAPHY PROCEDURE (1992) (0)
- [Changes of parameters of coagulation and fibrinolysis in disseminated intravascular coagulation]. (1973) (0)
- [Thrombotic tendency due to congenital disorders of coagulation or fibrinolysis (author's transl)]. (1980) (0)
- A case of platelet GPIIb/IIIa abnormality which shows lag time in ADP-induced aggregation (1987) (0)
- Dispositif d’alimentation en carburant (2005) (0)
- Status of the Research in the Field of Thrombosis and Hemostasis in Japan—Retrospective and Prospective Overviews (1997) (0)
- fibrins: its significance in hemostatic defect in factor XIII deficiency Differential binding of plasminogen to crosslinked and noncrosslinked (2011) (0)
- [Hypertension and stroke: screening methods]. (1980) (0)
- [Sustained high fever and hepatosplenomegaly: reactive reticulosis with appearance of Hodgkin-type cells]. (1975) (0)
- Immunological Difference between Blood and Placental Urokinase Inhibitor of Pregnant Women (1977) (0)
- Preparation of omega-(arylsulfonamido)-alkylamides (1975) (0)
- Acute effects of unsaturated fatty acids in splanchnic artery occlusion shock. (1989) (0)
- Anticoagulant and Antiplatelet Therapy in the Aged (1986) (0)
- Thrombomodulin: Its Expression and Releace into the Circulation (1993) (0)
- Thrombosis and Blood Coagulation/Fibrinolysis (1980) (0)
- Effects of Tissue Urokinase on Thrombin Plasminogen Activator and Human Platelet-dependent Generation in vitro (2014) (0)
- Mechanism of Thromblysis (1982) (0)
- Substance that binds to thrombin and process for their preparation. (1987) (0)
- [On the standardization in fibrinolysis assays (author's transl)]. (1976) (0)
- Educational lecture on hereditary abnormalities of blood coagulation and thrombosis. (1987) (0)
- [Early chest x-ray findings of ARDS--retrospective study on pulmonary complication of DIC (author's transl)]. (1980) (0)
- Throminbindende substance and process for their preparation. (1987) (0)
- Pompe d'alimentation en carburant (2005) (0)
- Hybridoma capable of producing monoclonal antibody for anti-thrombin binding substance (1992) (0)
- A case of acute promyelocytic leukemia (APL) followed by microgranular type APL. (1983) (0)
- [Endothelial damage and repair in myocardial ischemia and reperfusion]. (1993) (0)
- The plasma beta-thromboglobulin in ischemic heart disease (1980) (0)
- Proceedings: Inhibition of platelet cyclic AMP phosphodiesterase and platelet aggregation. (1974) (0)
- [Clinical problems of the natural coagulation and fibrinolysis inhibitors--introduction (author's transl)]. (1978) (0)
- [Progress in diagnosis of disseminated intravascular coagulation (DIC)--diagnostic criteria of DIC]. (1993) (0)
- [Releasing function of the platelets (with special reference to 14C-serotonin release]. (1979) (0)
- Genetic risk factors for coronary artery disease (1998) (0)
- [Serum protein fraction values and frequency of M-protein isolation in geriatric examinations]. (1971) (0)
- [Hereditary abnormalities of blood coagulation and thrombosis]. (1987) (0)
- Survival of transfused alpha 2-plasmin inhibitor in a patient with its congenital deficiency. (1981) (0)
- Monoclonal antibodies against Antithrombinbindende substance and its uses. (1988) (0)
- Recent progress in hematology. DIC. (1987) (0)
- Preparation of plasminogen - free fibrinogen; starting from fibrinogen prepared by improved freezing thawing method. (1969) (0)
- Potentiation by collagen or epinephrine of platelet responsiveness to aggregation. The possible role of arachidonic acid released from platelet membranes (1977) (0)
- CLINICAL SIGNIFICANCE OF HYPOXIA WITHOUT CONGESTIVE HEART FAILURE IN ACUTE MYOCARDIAL INFARCTION (1995) (0)
- Reminiscences of my contributions to Thrombosis and Haemostasis: Urine tissue factor and plasma plasmin inhibitor (2007) (0)
- [Algorithm for calculating blood base excess from pH bicarbonate diagram (author's transl)]. (1980) (0)
- [Review of recent studies of hemostasis and the mechanism of thrombosis]. (1974) (0)
- -35- MECHANISM OF PROTECTION OF REPERFUSION INJURY BY FREE RADICAL SCAVENGER : ROLE OF ENDOTHELIAL CELL PRESERVATION : Coronary Circulation : FREE COMMUNICATIONS(I) : PROCEEDINGS OF THE 51th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY (1987) (0)
- [Studies on the regulatory mechanisms of platelet aggregation (author's transl)]. (1979) (0)
- [Review on internal medicine (1986). Recent progress in hematology. 7. DIC]. (1987) (0)
- Peptide of a2-Plasmin Inhibitor (2005) (0)
- α 2 -Makroglobulin und Protease Nexin 1: Struktur und Funktion (1999) (0)
- [Puncture biopsy of the kidney and prostatic neoplasms]. (1980) (0)
- Thrombin-binding substance and process for preparing thethrombin-binding substance and process for preparing the same same (1987) (0)
- [Reactions of alpha 2 plasmin inhibitor to plasmin and fibrin; its significance in fibrinolysis inhibition and hemostasis]. (1982) (0)
- different molecular weight Thrombasthenia with an abnormal platelet membrane glycoprotein IIb of (2005) (0)
- Augmentation of thrombin generation during exercise or mental stress (1996) (0)
- [Clinical and laboratory studies on cefoxitin in the field of digestive system (author's transl)]. (1980) (0)
- Two cases of connective tissue diseases complicated with thrombotic thrombocytopenic purpura (1990) (0)
- [Cortisol measurement using solid-phase radioimmunoassay (author's transl)]. (1981) (0)
- [A family of hereditary refractory sideroblastic anemia with markedly reduced delta-aminolevulinic acid synthetase activity in bone marrow erythroblasts]. (1976) (0)
- Effects of Tissue Plasminogen Activator and Urokinase on Human Platelet-dependent Thrombin Generation in vitro (2000) (0)
- [Antithrombin 3. Its physicochemical properties and pathophysiological significance (author's transl)]. (1973) (0)
- Efficacy and Safety of Recombinant Human Soluble Thrombomodulin (ART-123) in Disseminated Intravascular Coagulation (DIC): Results of Phase III Randomized, Double-Blind, Clinical Trial. (2006) (0)
- -46-IDENTIFICATION AND QUANTIFICATION OF FREE RADICALS IN THE MYOCARDIUM WITH ESR SIGNALS (1986) (0)
- Studies for Mechanisms of Impaired Secretion of α2-Plasmin Inhibitor (1996) (0)
- [The biochemistry of fibrinolysis]. (1966) (0)
- [Protein C--possible usefulness as a therapeutic weapon]. (1990) (0)
- [Dic, thrombophlebitis--paraneoplastic syndromes---statistics and etiological mechanism]. (1980) (0)
- [Mechanism of hemostasis and thrombosis formation]. (1991) (0)
- [Electrophoresis of immunoglobulins, with special reference to M-protein]. (1972) (0)
- Reperfusion in Cats (2005) (0)
- [New trend of research on thrombosis and hemostasis; molecular biology]. (1989) (0)
- [Changes in blood chemical components in the aged]. (1971) (0)
- [Thrombolytic mechanism and its therapeutic application]. (1986) (0)
- [Emergency tests. The clinicopathological viewpoint: the standpoint of the general hospital]. (1974) (0)
- [Pathophysiology and treatment of thrombosis. (3) Protein C deficiency and thrombosis]. (1987) (0)
- [Standard value of prolactin and significance of metoclopramide test, with special reference to normal subjects and patients with thyroid diseases]. (1977) (0)
- [Radioimmunoassay of serum free thyroxine with microencapsulation system--its clinical use]. (1982) (0)
- [The change of antithrombin III activity of pregnant women and women on oral contraceptives (author's transl)]. (1977) (0)
- Distinction of Plasma Inhibitor of Activator-Induced Clot Lysis from Antiplasmins (1975) (0)
- [Contribution of Japanese researchers to progress in the field of hematology in the last 100 years: Congenital deficiency of alpha2-plasmin inhibitor]. (2002) (0)
- [Analysis in the coronary artery resistance during reperfusion after myocardial ischemia]. (1988) (0)
- Detection of plasminogen variants by electrofocusing and frequency distribution of plasminogen phenotypes (1984) (0)
- .omega.-(ARYLSULFAMIDE)-ALKYLAMINE (1975) (0)
- Monoclonal antibodies binding substance antithrombin and their uses. (1988) (0)
- Benign intracranial hypertension. (1985) (0)
- [A case of ankylosing spondylitis associated with hyperthyroidism and mesangial proliferative glomerulonephritis]. (1987) (0)
- [Study on the cell morphology and serum viscosity in myeloma, with special reference to the significance of enlarged rough endoplasmic reticulum]. (1968) (0)
- Anticorps monoclonaux contre une substance se liant a la thrombine, hybridomes produisant ces anticorps, methode de purification et detection de la substance se liant a la thrombine a l'aide de ces anticorps monoclonaux (1988) (0)
- News omega- (arylsulfonamido) alkylamine, their process for the preparation and application in therapeutic (1975) (0)
- 1006-44 A Prognostic Factor in Coronary Artery Disease (CAD): Platelet-Dependent Thrombin Generation in Patients with CAD (1995) (0)
- 3) Protein C Deficiency and Thrombosis (1987) (0)
- [Analysis of alpha 2-plasmin inhibitor]. (1985) (0)
- [Blood concentrations of thrombomodulin in patients with various diseases]. (1994) (0)
- A case of Crohn's disease associated with Sjögren's syndrome, who in addition met the diagnostic criteria for systemic lupus erythematosus (1992) (0)
- [Role of adenylate cyclase and the mechanism controlling platelet aggregation]. (1979) (0)
- Inhibition Of Platelet Aggregation And Release Reaction By A Calmodulin Interacting Agent, N-(6-Aminohexyl)-5-Chloro-1-Naphthalene Sulfonamide (1981) (0)
- Clinical Valuableness of the Measurement of Thrombin/Antithrombin III Complex (1990) (0)
- Isolation and characterization of α2-plasmin inhibitor brom human plasma (1978) (0)
- [Pathophysiological analysis of diabetes mellitus and complications from the urine of diabetic patients]. (1992) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Nobuo Aoki?
Nobuo Aoki is affiliated with the following schools: